BioSpace News Archive

The global clinical trial management system market is expected to rise due to the augmented use of these systems, increased R&D investment by life science and clinical research organizations, and the rapid expansion of healthcare IT sector.

Fact.MR – A Market Research and Competitive Intelligence Provider: The hormone replacement therapy market is projected to grow at a robust pace during the forecast period from 2018 to 2028, predicts Fact.MR.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per the study by Fact.MR, the global aptamers market is projected to exhibit stellar growth at 21% CAGR during the forecast period between 2020 to 2025.

The automated suturing devices market is predicted to grow at a noticeable pace during the forecast period.

According to the report, the global AI in drug discovery market was valued at US$ 0.35 Bn in 2020 and is projected to expand at a CAGR of 36.1% from 2021 to 2031.

According to the report, the global veterinary molecular diagnostics market was valued at US$ 479.3 Mn in 2019 and is projected to expand at a CAGR of ~8% from 2020 to 2030.

C4 Therapeutics, Inc. today announced its inclusion on the NASDAQ Biotechnology Index (Nasdaq: NBI), effective on December 20, 2021.

LifeSci Partnering & Analytics, a division of LifeSci Partners, today announced the launch of LifeSci Consulting through a business combination with Corsica Life Sciences.

Erasca, Inc. today announced the United States Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for ERAS-801.

Hyloris Pharmaceuticals SA, a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, announces that it has entered into a strategic collaboration with Vaneltix Pharma, Inc. for the development and commercialisation of AlenuraTM as first-line drug treatment for acute pain in interstitial cystitis /bladder pain syndrome.